Nshimyiryo, Alphonse
Barnhart, Dale A.
Cubaka, Vincent K.
Dusengimana, Jean Marie Vianney
Dusabeyezu, Symaque
Ndagijimana, Deogratias
Umutesi, Grace
Shyirambere, Cyprien
Karema, Nadine
Mubiligi, Joel M.
Kateera, Fredrick
Article History
Received: 18 January 2021
Accepted: 6 April 2021
First Online: 10 April 2021
Declarations
:
: This study received approval from the PIH/IMB research committee and was conducted under umbrella protocols of all involved clinical programs (MH: 196/RNEC/2020; NCD: 910/RNEC/2019; HIV: 015/RNEC/2020; Oncology: 805/RNEC/2019 and PDC: 713/RNEC/2019) as approved by the Rwanda National Ethics Committee (RNEC). All methods were carried out in accordance with relevant guidelines and regulations for research involving human subjects. Patients (or their primary caregivers) aged 18 years or older were given a detailed explanation about the purpose of the study and asked to provide a verbal consent for their voluntary participation. Informed verbal consent was obtained from all participants or from a parent/legal guardian for participants who were under 18 years of age.
: Not applicable.
: None declared.